Chimaeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy

Conference Article| November 01 1995 Chimaeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy G. Gross; G. Gross ‡ *Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100 Israel Search for other works by this author on: This Site PubMed Google Scholar S. Levy; S. Levy †Division of Oncology M-207, Stanford University School of Medicine, Stanford, CA 94305, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar R. Levy; R. Levy †Division of Oncology M-207, Stanford University School of Medicine, Stanford, CA 94305, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar T. Waks; T. Waks *Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100 Israel Search for other works by this author on: This Site PubMed Google Scholar Z. Eshhar Z. Eshhar § *Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100 Israel §To whom correspondence should be addressed. Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1995) 23 (4): 1079–1082. https://doi.org/10.1042/bst0231079 Article history Received: June 21 1995 Views Icon Views Article contents Figures Chimaeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy. Biochem Soc Trans 1 November 1995; 23 (4): 1079–1082. doi: https://doi.org/10.1042/bst0231079 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: 38C13, mouse lymphoma expressing surface IgM, S1C5, anti-38C13 idiotype, cTCR, chimaeric T-cell receptor, MHC, major histocompatability This content is only available as a PDF. © 1995 Biochemical Society1995 Article PDF first page preview Close Modal You do not currently have access to this content.